141
Views
0
CrossRef citations to date
0
Altmetric
Review

Regenerative Medicine for Neuropathic Pain: Physiology, Ultrasound and Therapies with a Focus on Alpha-2-Macroglobulin

, ORCID Icon &
Pages 779-793 | Received 09 Jan 2022, Accepted 14 Jun 2022, Published online: 28 Jun 2022

References

  • Kankowski S , GrotheC , Haastert-TaliniK , BarrotM. Neuropathic pain: spotlighting anatomy, experimental models, mechanisms, and therapeutic aspects. Eur. J. Neurosci.54(2), 4475–4496 (2021).
  • Misery L . Pruriplastic itch-a novel pathogenic concept in chronic pruritus. Front. Med.7, 615118 (2021).
  • Shah H , KodackE , WalkerJ. Neuropathic pain: a review of pathophysiology, presentation, and management. Topics Pain Management35(8), 1–7 (2020).
  • Hansson P , BaronR , StubhaugA. Acute neuropathic pain: equivalent or different to chronic neuropathic pain? A call for gathering of scientifically based information on acute neuropathic pain. Pain160(11), 2413–2414 (2019).
  • Doshi T , DworkinR , PolomanoRet al. AAAPT diagnostic criteria for acute neuropathic pain. Pain Med. Advance Article1–1 (2021).
  • Scholz J , FinnerupN , AttalNet al. The IASP classification of chronic pain for ICD-11: chronic neuropathic pain. Pain160(1), 28–37 (2019).
  • Moisset X , BouhassiraD. Brain imaging of neuropathic pain. Neuroimage37(1), S80–S88 (2007).
  • Pelosi L , MingYin Tse D , MulroyE , ChancellorAM , BolandMR. Ulnar neuropathy with abnormal non-localizing electrophysiology: clinical, electrophysiological, and ultrasound findings. Clin. Neurophysiol.29(10), 2155–2161 (2018).
  • Garcia-Larrea L , HagiwaraK. Electrophysiology in diagnosis and management of neuropathic pain. Rev. Neurol. (Paris)175(1-2), 26–37 (2019).
  • Pelosi L , MulroyE. Diagnostic sensitivity of electrophysiology and ultrasonography in ulnar neuropathies of different severity. Clin. Neurophysiol.130(2), 297–302 (2019).
  • Karabay I , DemirY , KorogluO , AslanSG , AydemirK , GurkayE. Assessment of lower limb peripheral nerves with ultrasound in patients with traumatic amputation. Turk. J. Phys. Med. Rehabil.67(3), 3357–3364 (2021).
  • Bianchi S , BeccioliniM , UrigoC. Ultrasound imaging of disorders of small nerves of the extremities: less recognized locations. J. Ultrasound Med.38(11), 2821–2842 (2019).
  • Coraci D , CapobiancoSV , RomanoMet al. Neuropathic pain and ultrasonography: a multiperspective literature evaluation. Diagnostics (Basel)11(9), 1705 (2021).
  • Van Hecke O , AustinSK , KhanRA , SmithB , TorranceN. Neuropathic pain in the general population: a systematic review of epidemiological studies. Pain155, 654–662 (2014).
  • Balzani E , FanelliA , MalafogliaVet al. A review of the clinical and therapeutic implications of neuropathic pain. Biomedicines9(9), 1239 (2021).
  • Finnerup NB , KunerR , JensenTS. Neuropathic pain: from mechanisms to treatment. Physiol. Rev.101(1), 259–301 (2021).
  • Franchi S , CastelliM , AmodeoGet al. Adult stem cell as new advanced therapy for experimental neuropathic pain treatment. Biomed. Res. Int.2014, 470983 (2014).
  • Liu M , LiK , WangY , ZhaoG , JiangJ. Stem cells in the treatment of neuropathic pain: research progress of mechanism. Stem Cells Int.2020, 8861251 (2020).
  • Arandjelovic S , DragojlovicN , LiX , MyersRR , CampanaWM , GoniasSL. A derivative of plasma protease inhibitor alpha(2)-macroglobulin regulates the response to peripheral nerve injury. J. Neurochem.103(2), 694–705 (2007).
  • Kocot-Kępska M , ZajączkowskaR , MikaJ , WordliczekJ , DobrogowskiJ , Przeklasa-MuszyńskaA. Peripheral mechanisms of neuropathic pain – the role of neuronal and non-neuronal interactions and their implications for topical treatment of neuropathic pain. Pharmaceuticals (Basel)14(2), 77 (2021).
  • Calvo M , BennettDLH. The mechanisms of microgliosis and pain following peripheral nerve injury. Exp. Neurol.234(2), 271–282 (2012).
  • Zhou M , WuG , WuL. Neuronal and microglial mechanisms of neuropathic pain. Mol. Brain.4(1), 1–12 (2011).
  • Ward H , WestS. Microglia: sculptors of neuropathic pain. R. Soc. Open Sci.7(6), 1–23 (2020).
  • García-Fernández P , ÜçeylerN , SommerC. From the low-density lipoprotein receptor-related protein 1 to neuropathic pain: a potentially novel target. Pain Rep.6(1), e898 (2021).
  • Domoto R , SekiguchiF , TsubotaM , KawabataA. Macrophage as a peripheral pain regulator. Cells10(8), 1881 (2021).
  • Ji A , XuJ. Neuropathic pain: biomolecular intervention and imaging via targeting microglia activation. Biomolecules11(9), 1343 (2021).
  • Kohno K , TsudaM. Role of microglia and P2X4 receptors in chronic pain. Pain Rep.6(1), e864 (2021).
  • Trang T , BeggsS , WanX , SalterMW. P2X4-receptor-mediated synthesis and release of brain-derived neurotrophic factor in microglia is dependent on calcium and p38-mitogen-activated protein kinase activation. J. Neurosci.29(11), 3518–3528 (2009).
  • Huang L , JinJ , ChenKet al. BDNF produced by cerebral microglia promotes cortical plasticity and pain hypersensitivity after peripheral nerve injury. PLoS Biol.19(7), e3001337 (2021).
  • Thibault K , LinWK , RancillacAet al. BDNF-dependent plasticity induced by peripheral inflammation in the primary sensory and the cingulate cortex triggers cold allodynia and reveals a major role for endogenous BDNF As a tuner of the affective aspect of pain. J. Neurosci.34(44), 14739–14751 (2014).
  • Cichon J , BlanckTJJ , GanWB , YangG. Activation of cortical somatostatin interneurons prevents the development of neuropathic pain. Nat. Neurosci.20(8), 1122–1132 (2017).
  • Inoue K , TsudaM. Microglia in neuropathic pain: cellular and molecular mechanisms and therapeutic potential. Nat. Rev. Neurosci.19(3), 138–152 (2018).
  • Kawasaki Y , ZhangL , ChengJK , JiRR. Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin-1β, intereleukin-6 and tumor necrosis factor-α in regulating synaptic and neuronal activity in the superficial spinal cord. J. Neurosci.28(20), 5189–5194 (2008).
  • Viviani B , BartisaghiS , GardoniFet al. Interleukin-1β enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J. Neurosci.23(25), 8692–8700 (2003).
  • Clark AK , MalcangioM. Fractalkine/CX3CR1 signaling during neuropathic pain. Front Cell Neurosci.8, 121 (2014).
  • Kim D , KimMA , ChoIHet al. A critical role of Toll-like receptor 2 in nerve injury-induced spinal cord glial cell activation and pain hypersensitivity. J. Biol. Chem.282(20), 14975–14983 (2007).
  • Ye G , LinC , ZhangYet al. Quercetin alleviates neuropathic pain in the rat CCI model by mediating AMPK/MAPK pathway. J. Pain Res.14, 1289–1301 (2021).
  • Wagner R , MyersRR. Endoneurial injection of TNF-α produces neuropathic pain behaviours. Neuroreport7(18), 2897–2901 (1996).
  • Sorkin LS , XiaoWH , WagnerR , MyersRR. Tumor necrosis factor-α induces ectopic activity in nociceptive primary afferent fibers. Neuroscience81(1), 255–262 (1997).
  • Myers RR , CampanaWM , ShubayevVI. The role of neuroinflammation in neuropathic pain: mechanisms and therapeutic targets. Drug Discov. Today11(1-2), 8–20 (2006).
  • Peng J , YiM , JeongHet al. The voltage-gated proton channel Hv1 promotes microglia-astrocyte communication and neuropathic pain after peripheral nerve injury. Mol. Brain14(1), 99 (2021).
  • Giray E , AtalayK , ŞiraziS , AlpM , YagciI. An ultrasonographic and electromyographic evaluation of jumping stump possibly due to a neuroma in a patient with transradial amputation: a case report. J. Back Musculoskelet. Rehabil.34(1), 33–37 (2021).
  • Coraci D , CapobiancoS , RomanoMet al. Neuropathic pain and ultrasonography: a multiperspective literature evaluation. Diagnostics (Basel)11(9), 1705 (2021).
  • Wu YY , GuoXY , ChenK , HeFD , QuanJR. Feasibility and reliability of an ultrasound examination to diagnose piriformis syndrome. World Neurosurg.134, e1085–e1092 (2020).
  • Forte A , BoczarD , OliverJ , SistiA , ClendenenS. Ultra-high-frequency ultrasound to assess nerve fascicles in median nerve traumatic neuroma. Cureus11(6), e4871 (2019).
  • Park YH , KimTJ , ChoiGW , KimHJ. Prediction of clinical prognosis according to intermetatarsal distance and neuroma size on ultrasonography in Morton neuroma: a prospective observational study. J. Ultrasound Med.38(4), 1009–1014 (2019).
  • Orduña Valls J , SotoE , FerrandisMartínez M , NebredaC , TorneroTornero C. Cervical plexus as anatomical target for the treatment of postoperative cervical neuropathic pain. J. Pain Res.12, 1217–1221 (2019).
  • Chang K , KimS. Editorial: use of ultrasound in diagnosis and treatment of peripheral nerve entrapment syndrome. Front in Neurol.10, 1348 (2010).
  • Jacobson J , JebsonP , JeffersA , FessellD , HayesC. Ulnar nerve dislocation and snapping triceps syndrome: diagnosis with dynamic sonography-report of three cases1. Radiology220(3), 601–605 (2001).
  • Arnold D , WilkensS , CoertJ , ChenN , DucicI , EberlinK. Diagnostic criteria for symptomatic neuroma. Ann. Plast. Surg.82(4), 420–427 (2019).
  • Ruiz Santiago F , PradosOlleta N , TomasMunoz P , GuzmanAlvarez L , MartinezMartinez A. Short term comparison between blind and ultrasound guided injection in Morton Neuroma. Eur. Radiol.29(2), 620–627 (2019).
  • Coraci D , LoretiC , PaduaL. Peripheral nerve blocks for hand procedures. N. Engl. J. Med.379(22), 2181–2182 (2018).
  • Lam K , HungC , ChiangYet al. Ultrasound-guided nerve hydrodissection for pain management: rationale, methods, current literature, and theoretical mechanisms. J. Pain Res.13, 1957–1968 (2020).
  • Kara M , OzcakarL , TiftikT. Sonographic evaluation of sciatic nerves in patients with unilateral sciatica. Arch. Phys. Med. Rehabil.93(9), 1598–1602 (2012).
  • Chen KH , LeeKF , HsuHC , HuangWC , HsiaoKY , FangKM. The role of high-resolution ultrasound in the diagnosis of a traumatic neuroma in an injured median nerve. Am. J. Phys. Med. Rehabil.88(9), 771–774 (2009).
  • Jacobson JA , WilsonTJ , YangLJS. Sonography of the common peripheral nerve disorders with clinical correlation. J. Ultrasound Med.35(4), 683–693 (2016).
  • Kalia V , JacobsonJA. Imaging of the peripheral nerves of the extremities. Radiol. Clin. N. Am.57(5), 1063–1071 (2019).
  • Perrot S , PickeringG , Lantéri-MinetM , AttalN. Real-life management pathways for chronic peripheral neuropathic pain at tertiary pain clinics in France. Pain Med.22(4), 875–882 (2021).
  • Hadi MA , AlldredDP , BriggsM , MarczewskiK , ClossSJ. Treated as a number, not treated as a person: a qualitative exploration of the perceived barriers to effective pain management of patients with chronic pain. BMJ Open7(6), e016454 (2017).
  • Viswanath O , UritsI , JonesM. Membrane stabilizer medications in the treatment of chronic neuropathic pain: a comprehensive review. Curr. Pain Headache Rep.23(6), 37 (2019).
  • Sałat K , GryzłoB , KuligK. Experimental drugs for neuropathic pain. Curr. Neuropharmacol.16(8), 1193–1209 (2018).
  • Bates D , SchultheisB , HanesM. A comprehensive algorithm for management of neuropathic pain. Pain Med.20(Suppl. 1), S2–S12 (2019).
  • Vaquero J , ZuritaM , RicoMAet al. Intrathecal administration of autologous of bone marrow stromal cells improves neuropathic pain in patients with spinal cord injury. Neurosci. Lett.670, 14–18 (2018).
  • Levi AD , OkonkwoDO , ParkPet al. Emerging safety on intramedullary transplantation of human stem cells in chronic cervical and thoracic spinal cord injury. Neurosurgery82(4), 562–575 (2018).
  • Liu L , HuaZ , ShenJet al. Comparative efficacy of multiple variables of mesenchymal stem cell transplantation for the treatment of neuropathic pain in rats. Military Medicine182(S1), 175–184 (2017).
  • Padda J , KhalidK , ZubairUet al. Stem cell therapy and its significance in pain management. Cureus13(8), e17258 (2021).
  • Vadivelu S , WillseyM , CurryDJ , McDonaldJW. Potential role of stem cells for neuropathic pain disorders. Neurosurg. Focus35(3), E11 (2013).
  • Trallori E , GhelardiniC , DiCesare Mannelli L. Mesenchymal stem cells, implications for pain therapy. Neural. Regen. Res.14(11), 1915–1916 (2019).
  • Joshi H , JoH , KimY , AnS , ParkC , HanI. Stem cell therapy for modulating neuroinflammation in neuropathic pain. Int. J. Mol. Sci.22(9), 4853 (2021).
  • Siniscalco D , GiordanoC , GalderisiUet al. Long lasting effects of human mesenchymal stem cell systemic administration on pain-like behaviours, cellular and biomolecular modifications in neuropathic mice. Front Integr. Neurosci.5, 79 (2011).
  • Kuffler D . Platelet-rich plasma and the elimination of neuropathic pain. Mol. Neurobiol.48(2), 315–332 (2013).
  • Kuffler D . Mechanisms for reducing neuropathic pain. Mol. Neurobiol.57(1), 67–87 (2020).
  • Bohren Y , TimbolschiDI , MullerA , BarrotM , YalcinI , SalvatE. Platelet rich plasma and cytokines in neuropathic pain: a narrative review and a clinical perspective. Eur. J. Pain26(1), 43–60 (2021).
  • Hassanien M , ElawamyA , KamelEZet al. Perineural platelet-rich plasma for diabetic neuropathic pain, could it make a difference? Pain Med. 21(4), 757–765 (2020).
  • Chen SR , ShenRP , HoTYet al. One-year efficacy of platelet rich plasma for moderate to severe carpal tunnel syndrome: a prospective, randomized, double-blind, controlled trial. Archives of Phys. Med. Rehabil.102(5), 951–958 (2021).
  • Everts P , OnishiK , JayaramP , LanaJF , MautnerK. Platelet rich plasma: new performance understandings and therapeutic considerations in 2020. Int. J. Mol. Sci.21(20), 7794 (2020).
  • Dong C , SunY , QiYet al. Effect of platelet rich plasma injection on mild or moderate carpal tunnel syndrome: an updated systematic review and meta-analysis of randomized controlled trials. Biomed. Res. Int.2020, 5089378 (2020).
  • Hashim NA , FathyHA , EsawyMM , ShabanaMA. Comparison of efficiency between platelet rich plasma and corticosteroid injection therapies in patients with carpal tunnel syndrome: a prospective randomized controlled study. Egyptian J. Neurol. Psychiat. Neurosurg.56(59), (2020). https://doi.org/10.1186/s41983-020-00184-1
  • Ince B , YıldırımMC , KilincI , OltuluP , DadaciM. Investigation of the development of hypersensitivity and hyperalgesia after repeated application of platelet-rich plasma in rats: an experimental study. Aesthet Surg. J.39(10), 1139–1145 (2019).
  • Siniscalco D , RossiF , MaioneS. Stem cell therapy for neuropathic pain treatment. J. Stem Cells Regen. Med.3(1), 2–11 (2007).
  • Franchi S , CastelliM , AmodeoGet al. Adult stem cell as new advanced therapy for experimental neuropathic pain treatment. BioMed. Res. Int.2014, 470983 (2014).
  • Vickers ER , KarstenE , LilischkisR , FloodJ. A prelimary report on stem cell therapy for neuropathic pain in humans. J. Pain Res.7, 225–263 (2014).
  • Yamazaki K , KawaboriM , SekiTet al. Mesenchymal stem cell sheet promotes functional recovery and palliates neuropathic pain in a subacute spinal cord injury model. Stem Cells Int.2021, 9964877 (2021).
  • Han YH , KimKH , AbdiS , KimTK. Stem cell therapy in pain medicine. Korean J. Pain.32(4), 245–255 (2019).
  • Asgharzade S , TalaeiA , FarkhondehT , ForouzanfarF. A Review on stem cell therapy for neuropathic pain. Curr. Stem. Cell Res. Ther.15(4), 349–361 (2020).
  • Zhu M , ZhaoB , WeiL , WangS. Alpha-2-macroglobulin, a native and powerful proteinase inhibitor, prevents cartilage degeneration disease by inhibiting majority of catabolic enzymes and cytokines. Current Mol. Bio. Rep.7(1), 1–7 (2021).
  • Pizzo SV , GoniasSL. Receptor-mediated protease regulation. Academic Press1, 178–221 (1984).
  • Feldman SR , GoniasSL , PizzoSV. Model of alpha-2 macroglobulin structure and function. Proc. Natl Sci. Acad. USA82(17), 5700–5704 (1985).
  • Harwood S , LyngsøJ , ZarantonelloAet al. Structural investigations of human a2m identify a hollow native conformation that underlies its distinctive protease-trapping mechanism. Mol. Cell Proteomics20, 100090 (2010).
  • Wei L . Intra-articular injection of alpha-2 macroglobulin prevents post-traumatic osteoarthritis. Defense Technical Information Center1–7 (2020). https://apps.dtic.mil/sti/citations/AD1117103
  • de Castro JC . Study on alpha-2 macroglobulin: the new weapon on neuropathic pains. Issues Developments in Medi. Med. Res.2, 17–21 (2022).
  • Vincenzetti S , PucciarelliS , HuangYet al. Biomarkers mapping of neuropathic pain in a nerve chronic constriction injury mice model. Biochimie158, 172–179 (2019).
  • LaMarre J , WollenbergGK , GoniasSL , HayesMA. Cytokine binding and clearance properties of proteinase-activated alpha-2-macroglobulins. Lab. Invest.65(1), 3–14 (1991).
  • de Castro J . Alpha-2-macroglobulin: the new weapon of neuropathic pains. J. Clin. Res. Anes4(1), (2018). https://www.auctoresonline.org/journals/international-journal-of-mediators-of-inflammation
  • Montesano PX , CuellarJM , ScuderiGJ. Intradiscal injection of an autologous alpha-2 macroglobulin concentrate alleviates back pain in FAC-positive patients. Ortho. Rheumatol.4(1), 42–46 (2017).
  • Brooks B , LeishearK , AronsonR. The use of alpha-2 macroglobulin as a novel treatment for patients with chronic pelvic pain syndrome. Int. J. Gyne Obstetrics152(3), 454–456 (2020).
  • Jordan S , IovineJ , KuhnT , GelabertH. Neurogenic thoracic outlet syndrome and other forms of cervical brachial syndrome treated with plasma concentrate enriched for alpha-2 macroglobulin. Pain Physician23(2), 229–233 (2020).
  • Gonias SL , CampanaWM. LDL receptor-related protein-1: a regulator of inflammation in atherosclerosis, cancer, and injury to the nervous system. Am. J. Pathol.184(1), 18–27 (2014).
  • Gama K , SantosD , EvangelistaA. Conditioned medium of bone marrow-derived mesenchymal stromal cells as a therapeutic approach to neuropathic pain: a preclinical evaluation. Stem Cells Int.2018, 8179013 (2018).
  • De Gregorio C , ContadorD , DiazDet al. Human adipose-derived mesenchymal stem cell-conditioned medium ameliorates polyneuropathy and foot ulceration in diabetic BKS db/db mice. Stem Cell Res. Ther.11(1), 168 (2020).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.